UICC TNM E-Learning Modules
eCancer and UICC jointly produced a set of 7 modules on TNM staging for the purpose of educating and informing the global cancer community on the globally accepted classification of malignant tumours.
The following modules are now available to download:
- Module 1: Introduction to the UICC TNM Classification System
- Module 2: UICC TNM Breast Cancer Classification
- Module 3:UICC TNM Prostate Cancer Classification
- Module 4:UICC TNM Colorectal Cancer Classification
- Module 5: UICC TNM Cervix Cancer Classification
- Module 6: UICC TNM Lip and Oral Cavity Cancer Classification
- Module 7: UICC TNM Lung Cancer Classification
Each module takes approximately 30 minutes to complete and includes a voice-over and interactive quiz.
By the end of each module, users should:
- know the general principles of the UICC TNM Classification of Malignant Tumours,
- understand the structure of the UICC TNM Classification 7th edition and
- be able to apply the UICC TNM Classification to different cancer sites
Learn more about eCancer.
The TNM Classification of Malignant Tumours 8th edition
James D. Brierley (Editor), Mary K. Gospodarowicz (Editor), Christian Wittekind (Editor)
The TNM Classification of Malignant Tumours, 8th Edition, published in 2016, provides the latest, internationally agreed-upon standards to describe and categorize cancer stages and progression. It contains important updated organ-specific classifications that oncologists and other professionals who manage patients with cancer need can use to accurately classify tumours for staging, prognosis and treatment.
For errata to the UICC TNM 8th edition click here.
The changes between the 7th and 8th editions have been updated with the corrections. Find out here.
The TNM Classification 7th is also available in many other languages. Published translations include:
Translations for the 8th edition are already in progress. Please see this website for any news regarding new translations.
For any queries about the classification, please visit the FAQ's page or ask your questions at the TNM Helpdesk.
Ovary, Fallopian Tube and Primary Peritoneal Carcinoma
FIGO has published a new classification for ovarian cancer.* This classification incorporates cancers of the fallopian tube and primary peritoneal carcinomas. These new cancer staging rules will be incorporated into the 8th Edition of the UICC TNM Classification of Malignant Tumours, which is scheduled for release in the Autumn of 2016, but will not become effective until January 1, 2017.
For a comparison of the current TNM for ovary and the new FIGO classification and proposal for the 8th edition go to this presentation.
*Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Jaime Prat; for the FIGO Committee on Gynecologic Oncology. International Journal of Gynecology and Obstetrics 124 (2014) 1–5
The TNM Supplement, 4th Edition
The TNM Supplement: A Commentary on Uniform Use, now in its 4th edition, extends and clarifies The Union for International Cancer Control (UICC) TNM Classification of Malignant Tumours, providing additional data that unifies the principles and practice of cancer staging.
The TNM Supplement provides explanations and examples to answer many questions that might arise in the course of the daily use of TNM, particularly in unusual cases. It enumerates the recommended criteria for pathological classification (pT and pN) and contains proposed classifications for new tumour sites and types that are not part of the official UICC TNM system yet.
Also available in German
TNM Atlas, 6th Edition
The TNM Atlas 6th Edition, as a companion for the TNM Classification, is designed as an aid for the practical application of the TNM classification system by illustrating the T and N categories in clear and easily understandable graphics. The aim of such a presentation is twofold: to enable all disciplines involved to reach a more standardized understanding and documentation of the anatomic spread of tumours, and to further enhance the dissemination and use of the TNM classification. The 6th edition of the TNM Atlas was released in May 2014.
Manual of Clinical Oncology, 9th Edition (2015)
The 9th edition of the Manual of Clinical Oncology adopts a multidisciplinary perspective and gathers expertise in different fields of cancer management to be used by all health professionals working in oncology. It aims to strike a balance between delivery of a high quality services and realities of the day-to-day practice, including that of resource-limited settings. The 9th edition was released in September 2015. 56 lead authors worked on various key cancer management and treatment issues and disease-specific approaches.
If you want to learn more about TNM or have any question about the publications, contact us at firstname.lastname@example.org
Other Wiley & UICC publications are available from the Wiley-Blackwell website.
Session at the World Cancer Congress in Paris 2 November 2016
Chaired by:Mary Gospodarowicz, Princess Margaret Cancer Centre (Canada)
- Cancer classifications a linchpin of clinical practice -Malcolm Mason, Cardiff University (United Kingdom)
Evolution of staging and prognostic classifications - Brian O'Sullivan, Princess Margaret Cancer Centre (Canada)
Universality - James Brierley, Princess Margaret Cancer Centre (Canada
Session at the World Cancer Congress in Melbourne 4 December 2014
Making Cancer Staging Globally Relevant
Chaired by: Dr Brian O'Sullivan (Canada)
- Recording stage of disease in cancer registries: Problems and solutions for Low and Middle Income Countries- Dr Max Parkin, African Network of Cancer Registries (United Kingdom)
- The need for simplified stage language for all - Dr James Brierley, Princess Margaret Hospital (Canada)
- Developing a simple TNM stage tool - Giulio Napolitano, Northern Ireland Cancer Registry (United Kingdom)
- Promoting TNM stage use/ensuring stage is globally relevant -Dr Anne Lee, The Hong Kong Anti-Cancer Society (Hong Kong)
Workshop at the World Cancer Congress in Montreal – 28 August 2012
Meet the expert: Cancer stage: a neglected cornerstone of cancer control
Chaired by: Mary Gospodarowicz (Canada)
Proposed by: UICC TNM prognostic factors core group
- Using population bases staging data to inform: cancer resource allocation, cancer screening and treatment guideline concordance - Dr James Brierley (Canada)
- Cancer staging and quality of care - Dr Christian Wittekind (Germany)
- The challenges of constructing a national staging strategy: a European perspective - Dr Malcolm Mason (United Kingdom)
- The challenges of constructing a national staging strategy: an Asian perspective - Dr Anne Lee (Hong Kong)
- Cancer staging in 2022 - Dr Brian O'Sullivan (Canada)
The History of TNM
Download the document: TNM History, Evolution & Milestones